Vanguard Capital Opportunity Inv (VHCOX)
82.87
+0.02 (+0.02%)
USD |
Jan 22
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.44% | 19.18B | 0.40% | 8.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -2.090B | 28.34% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks long-term capital appreciation. The fund invests mainly in U.S. stocks, with an emphasis on companies that are considered to have prospects for rapid earnings growth. It does not focus on companies of any particular size, however; the advisor may emphasize mid-cap stocks. The fund's investment advisor uses fundamental research to identify stocks that are expected to outperform the market over a three- to five-year time horizon and that are available at attractive prices relative to their fundamental values. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | VHCOX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Growth |
| Category Index | Russell 1000 Growth TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Vanguard |
| Prospectus Benchmark Index | |
| Russell Mid Cap Growth TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Joel Fried | 22.93 yrs |
| Theo Kolokotrones | 22.93 yrs |
| Alfred Mordecai | 21.02 yrs |
| M. Ansari | 13.01 yrs |
| James Marchetti | 5.93 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
96
-2.090B
-18.65B
Category Low
17.04B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of December 31, 2020
Performance Versus Category
As of January 22, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of January 22, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
Vanguard Market Liquidity Inv
|
4.28% | -- | -- |
| Eli Lilly and Co | 4.14% | 206.14 | 1.87% |
| Amgen Inc | 3.51% | 253.50 | 0.58% |
| Biogen Inc | 3.36% | 269.44 | -0.25% |
| Alibaba Group Holding Ltd ADR | 3.00% | 258.62 | -0.53% |
| Tesla Inc | 2.64% | 846.64 | 0.20% |
| Microsoft Corp | 2.60% | 225.95 | 0.44% |
| FedEx Corp | 2.57% | 254.08 | 0.06% |
| Seagen Inc Ordinary Shares | 2.44% | 182.75 | -1.63% |
| Biomarin Pharmaceutical Inc | 2.36% | 87.99 | 1.28% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | Upgrade |
| Administration Fee | -- |
| Performance Fee | -- |
| Switching Fee | -- |
| Transaction Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
Basic Info
| Investment Strategy | |
| The investment seeks long-term capital appreciation. The fund invests mainly in U.S. stocks, with an emphasis on companies that are considered to have prospects for rapid earnings growth. It does not focus on companies of any particular size, however; the advisor may emphasize mid-cap stocks. The fund's investment advisor uses fundamental research to identify stocks that are expected to outperform the market over a three- to five-year time horizon and that are available at attractive prices relative to their fundamental values. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | VHCOX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Growth |
| Category Index | Russell 1000 Growth TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Vanguard |
| Prospectus Benchmark Index | |
| Russell Mid Cap Growth TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Joel Fried | 22.93 yrs |
| Theo Kolokotrones | 22.93 yrs |
| Alfred Mordecai | 21.02 yrs |
| M. Ansari | 13.01 yrs |
| James Marchetti | 5.93 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (1-22-21) | 0.40% |
| 30-Day SEC Yield (1-15-21) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 26.90 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of September 30, 2020
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 8/14/1995 |
| Last Annual Report Date | 9/30/2020 |
| Last Prospectus Date | 1/31/2020 |
| Share Classes | |
| VHCAX | Inst |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |